Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.
A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma
Oral spray wintertime vitamin D3 supplementation has no impact on inflammation in Gaelic footballers